explore -WSS

explore

author：fashion 2025-09-28 18:20:35 - browse：2776

Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the company’s bid to secure Medicare coverage for its pricey blood-based cancer screening test that has been on the market for over a year but is not widely used.

A recently posted lobbying report indicates that, during the fourth quarter of last year, the biotech spent $1.07 million on “issues related to oncology and multi-cancer early detection,” including House and Senate bills that would allow Medicare to cover multi-cancer screening tests. That figure has been rising; during the fourth quarter of 2021, the company spent $470,000 on lobbying. That’s far more than cancer and genetic testing biotechs such as Guardant Health, Myriad Genetics, and Tempus, which spent anywhere from $90,000 to nearly $300,000 on lobbying last quarter.

The growing investment in lobbying elected officials comes at a time when Grail is looking to make its test, Galleri, available to a broader swath of the population. The test, launched in 2021, can detect early signs of more than 50 cancers among people who don’t have symptoms. That’s because cancer cells release bits of DNA into the bloodstream, and Galleri spots telltale modifications to this DNA.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： How artificial intelligence is being used to detect, treat cancer

WSS

As Taiwan prepares for anti

AbbVie dramatically boosts its spending on lobbying

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Obesity drugs seen as possible treatment for liver disease MASH

hotspot

explore

focus

Novavax promises a turnaround & Lilly roils the obesity market

PBM reform efforts get punted in Congress

Continuity nursing helped my family in our darkest PICU moments

Elizabeth Warren probes abortion access

Malaria cases in Florida and Texas: Here’s what you need to know

CDC backtracks, saying fully vaccinated people can go maskless indoors

DIEP, the 'gold standard' of breast reconstruction, is under threat

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

The cancer drug shortage isn’t new — and neither are the solutions

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

focus

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Why palliative psychiatry is worth discussing

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Providers still hesitate to prescribe buprenorphine, study finds

Why palliative psychiatry is worth discussing

Alabama IVF ruling threatens families facing fatal genetic disease

entertainment

leisure time

leisure time

Wikipedia